Edwards Lifesciences (EW) Raw Materials (2010 - 2026)

Edwards Lifesciences has reported Raw Materials for 13 years, with the latest figure at $202.4 million in Q1 2026.

• For the quarter ending Q1 2026, Raw Materials fell 21.91% year-over-year to $202.4 million; the trailing twelve-month figure through Mar 2026 stood at $202.4 million (down 21.91% YoY), and the FY2025 full-year result was $196.6 million, down 18.46% from the prior year.
• Raw Materials for Q1 2026 stood at $202.4 million, up from $196.6 million in the prior quarter.
• The five-year high for Raw Materials was $280.0 million in Q1 2024, with the low at $196.3 million in Q4 2023.
• Average Raw Materials over 4 years is $233.0 million, with a median of $237.3 million recorded in 2024.
• Year-over-year, Raw Materials grew 22.82% in 2024 and fell 21.91% in 2026.
• Tracing EW's Raw Materials over 4 years: stood at $196.3 million in 2023, then climbed by 22.82% to $241.1 million in 2024, then declined by 18.46% to $196.6 million in 2025, then rose by 2.95% to $202.4 million in 2026.
• The last three Raw Materials figures came in at $202.4 million (Q1 2026), $196.6 million (Q4 2025), and $222.8 million (Q3 2025), per Business Quant data.

Peer Comparison